ProfileGDS4132 / 240937_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 31% 34% 34% 36% 35% 29% 31% 31% 31% 28% 33% 30% 30% 33% 34% 30% 31% 32% 31% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10176.104131
GSM201543Muscle PCOS pioglitazone 12177.987134
GSM201544Muscle PCOS pioglitazone 16186.89134
GSM201545Muscle PCOS pioglitazone 20199.348836
GSM201829Muscle PCOS pioglitazone 23195.994835
GSM201830Muscle PCOS pioglitazon 25173.561929
GSM201831Muscle PCOS pioglitazone 27175.522531
GSM201832Muscle PCOS pioglitazone 3178.311231
GSM201833Muscle PCOS pioglitazone 4173.550931
GSM201834Muscle PCOS pioglitazone 8166.247528
GSM201835Muscle PCOS after pioglitazone 10267.542233
GSM201836Muscle PCOS after pioglitazone 12262.19730
GSM201837Muscle PCOS after pioglitazone 16261.737930
GSM201838Muscle PCOS after pioglitazone 20273.415933
GSM201839Muscle PCOS after pioglitazone 23279.423534
GSM201840Muscle PCOS after pioglitazone 25268.960330
GSM201841Muscle PCOS after pioglitazone 27262.717531
GSM201842Muscle PCOS after pioglitazone 3263.609432
GSM201843Muscle PCOS after pioglitazone 4273.81131
GSM201844Muscle PCOS after pioglitazone 8264.700529